Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Return on Sales (2018 - 2025)

Health Catalyst's Return on Sales history spans 8 years, with the latest figure at 1.22% for Q4 2025.

  • For Q4 2025, Return on Sales fell 96.0% year-over-year to 1.22%; the TTM value through Dec 2025 reached 0.57%, down 35.0%, while the annual FY2025 figure was 0.57%, 35.0% down from the prior year.
  • Return on Sales reached 1.22% in Q4 2025 per HCAT's latest filing, down from 0.29% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.18% in Q2 2024 to a low of 1.22% in Q4 2025.
  • Average Return on Sales over 5 years is 0.47%, with a median of 0.45% recorded in 2023.
  • Peak YoY movement for Return on Sales: skyrocketed 37bps in 2023, then plummeted -96bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.76% in 2021, then soared by 32bps to 0.52% in 2022, then rose by 22bps to 0.4% in 2023, then soared by 36bps to 0.26% in 2024, then plummeted by -369bps to 1.22% in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Return on Sales are 1.22% (Q4 2025), 0.29% (Q3 2025), and 0.51% (Q2 2025).